My first inclination would be to go with a holding company like Berkshire Hathaway because it's invested in many other publicly traded companies. The company's focus on regional product fulfillment close to its end-customers is paying off...
Continue ReadingAmazon wants to dominate the three core layers of artificial intelligence: infrastructure, large language models, and software...
Continue ReadingRigetti Computing raised $12 million in Q3 but still reported a $17.3 million operating loss. See why I think IONQ is a potentially better investment than RGTI...
Continue ReadingAmazon's strategic move to release holiday film Red One in theaters before streaming on Prime Video aims to boost subscriber growth and maximize impact. See more...
Continue ReadingMag 7 tech giants reported strong earnings results for Sept. quarter with stock valuations appearing stretched, suggesting a cautious approach. Read more here...
Continue ReadingThere are long-term dividend investments with high yields and growth potential. Read about five selections for a dividend portfolio...
Continue ReadingNHTSA slaps Ford with $165M fine for failing to timely issue recall. GM's Cruise to pay $500,000 fine for false report on car crash. Hims & Hers cut to underperform over Amazon competition...
Continue ReadingFor Q3 2024, Fidelity Magellan Fund gained 3.28%, trailing the 5.89% advance of the benchmark S&P 500® index. Click here to read the full commentary...
Continue ReadingAdvanced Micro Devices (AMD), Intel (INTC), and Taiwan Semiconductor Manufacturing (TSM) are major players in the chipmaking and artificial intelligence (AI) segment but have seen varying degrees of success over the past two years — none have experienced Nvidia’s (NVDA) groundbreaking success. Personally, I’m bearish on Intel and TSMC, but I’m bullish on AMD, expecting it to experience continued market share gains and share price appreciation over the medium term. While AMD is unlikely to reach...
Continue ReadingShares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup. Amazon on Thursday launched the treatments through its One Medical telehealth service, and Amazon Prime members are eligible for free shipping, the company said. Hims & Hers’s stock fell 24% Thursday...
Continue Reading© 2026 Market News — All rights reserved